HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Longbin Liu Selected Research

Atherosclerotic Plaque (Atheroma)

6/2010Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout mice.
7/2009Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Longbin Liu Research Topics

Disease

13Huntington Disease (Huntington's Disease)
12/2023 - 01/2020
10Neoplasms (Cancer)
01/2020 - 07/2008
5Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 04/2020
4Disease Progression
01/2022 - 01/2020
4Atherosclerosis
10/2012 - 07/2009
3Alzheimer Disease (Alzheimer's Disease)
12/2023 - 01/2021
2Nervous System Diseases (Neurological Disorders)
01/2021 - 04/2020
2Atherosclerotic Plaque (Atheroma)
06/2010 - 07/2009
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2021
1Newborn Respiratory Distress Syndrome
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Brain Diseases (Brain Disorder)
01/2020
1Communicable Diseases (Infectious Diseases)
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
07/2018
1Hyperplasia
01/2016
1Diabetes Mellitus
12/2013
1Insulin Resistance
10/2012
1Carcinogenesis
03/2012
1Neoplasm Metastasis (Metastasis)
03/2012
1Hyperhomocysteinemia
06/2010
1Coronary Disease (Coronary Heart Disease)
07/2009

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2018
4polyglutamineIBA
10/2023 - 01/2020
3Huntingtin ProteinIBA
12/2023 - 09/2023
3Glycoproteins (Glycoprotein)IBA
10/2022 - 01/2020
2pyrimidineIBA
12/2023 - 01/2021
2LigandsIBA
01/2022 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
12/2013 - 07/2009
2Rosuvastatin Calcium (Crestor)FDA Link
10/2012 - 07/2009
2Insulin (Novolin)FDA Link
10/2012 - 07/2009
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2012 - 09/2012
2Phosphotransferases (Kinase)IBA
03/2012 - 03/2011
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2010 - 01/2010
2LDL Receptors (LDL Receptor)IBA
06/2010 - 01/2010
2Matrix Metalloproteinases (MMPs)IBA
01/2010 - 07/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2008 - 07/2008
1Glutamine (L-Glutamine)FDA Link
01/2023
11- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA
01/2022
1Pulmonary Surfactants (Pulmonary Surfactant)IBA
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Keratin-14 (Keratin 14)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1SCH 23390IBA
01/2021
1Endothelin-1 (Endothelin 1)IBA
01/2021
1Amyloid beta-PeptidesIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
04/2020
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
04/2020
1Protein AggregatesIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1sotorasibIBA
01/2020
1NiclosamideFDA Link
01/2019
1nitazoxanide (NTZ)FDA Link
01/2019
1Angiotensin IIIBA
07/2018
1IgA receptor (protein B)IBA
01/2016
1Blood Glucose (Blood Sugar)IBA
12/2013
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2012
1Insulin Receptor Substrate ProteinsIBA
10/2012
1CholesterolIBA
10/2012
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
10/2012
14- (2- ((6- methoxypyridin- 3- yl)amino)- 5- ((4- (methylsulfonyl)piperazin- 1- yl)methyl)pyridin- 3- yl)- 6- methyl- 1,3,5- triazin- 2- amineIBA
09/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2012
1Proto-Oncogene Proteins c-metIBA
03/2012
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2012
1pyrazoloneIBA
03/2012
1Methionine (L-Methionine)FDA Link
06/2010
1Ethanol (Ethyl Alcohol)IBA
06/2010
1Heparin (Liquaemin)FDA LinkGeneric
01/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2009
1LipidsIBA
07/2009

Therapy/Procedure

7Therapeutics
01/2022 - 07/2009
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2021